| Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has excipient |
Excipient not declared |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) controlled drug category |
Controlled drug category No Controlled Drug Status |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Is a |
Adrenaline 150micrograms/0.3ml (1 in 2,000) solution for injection pre-filled disposable devices |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator |
NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has excipient |
Sodium metabisulfite |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has active ingredient |
Epinephrine |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has active ingredient |
Epinephrine |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
VMP prescribing status (attribute) |
Not recommended to prescribe as a VMP |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
VMP non-availability indicator |
Available |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has manufactured dose form |
Conventional release solution for injection |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Is a |
Anapen |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has specific active ingredient |
Epinephrine |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has dispensed dose form |
Conventional release solution for injection |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Is a |
Actual medicinal product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
VMP prescribing status (attribute) |
VMP not recommended to prescribe - patient training required |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has manufactured dose form |
Conventional release solution for injection |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
VMP prescribing status (attribute) |
Caution - AMP level prescribing advised |
true |
Inferred relationship |
Existential restriction modifier |
|
|
FHIR